The News

Press releases

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Read article

Genomics plc bolsters executive leadership team with two new hires


25 Nov 2022

Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.

Read article

Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches


10 Oct 2022

Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.

Read article

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

Read article

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Read article

Genomics plc’s integrated risk tool substantially improves coronary artery disease prediction


3 Mar 2021

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention

Read article

Genomics plc completes oversubscribed $30m funding round


1 Mar 2021

Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a $30m funding round. Some highlights include:
· Follows achievement of significant milestones in both its Precision Health and Therapeutics division
· Significant investment from leading life science investors Foresite Capital and F-Prime Capital
· Existing backers Oxford Sciences Innovation and Lansdowne Partners also participated
· Fundraise was oversubscribed
Genomics plc will use the funding to expand its work building a patient-centric, population health platform that unlocks a more proactive, precise and personalised form of healthcare.

Read article

Genomics plc grows its senior management team


5 Oct 2020

Daniel Vogel joins Genomics plc as Chief Financial Officer, adding international commercial and financial expertise.

Read article

Mitchell Harris joins Genomics plc as Chief Strategy Officer


9 Mar 2020

Genomics plc strengthens leadership team with the addition of Mitchell Harris as Chief Strategy Officer and Professor Gil McVean as Chief Information Officer.

Read article

Press releases

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Genomics plc bolsters executive leadership team with two new hires


25 Nov 2022

Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.

Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches


10 Oct 2022

Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Genomics plc’s integrated risk tool substantially improves coronary artery disease prediction


3 Mar 2021

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention

Genomics plc completes oversubscribed $30m funding round


1 Mar 2021

Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a $30m funding round. Some highlights include:
· Follows achievement of significant milestones in both its Precision Health and Therapeutics division
· Significant investment from leading life science investors Foresite Capital and F-Prime Capital
· Existing backers Oxford Sciences Innovation and Lansdowne Partners also participated
· Fundraise was oversubscribed
Genomics plc will use the funding to expand its work building a patient-centric, population health platform that unlocks a more proactive, precise and personalised form of healthcare.

Genomics plc grows its senior management team


5 Oct 2020

Daniel Vogel joins Genomics plc as Chief Financial Officer, adding international commercial and financial expertise.

Mitchell Harris joins Genomics plc as Chief Strategy Officer


9 Mar 2020

Genomics plc strengthens leadership team with the addition of Mitchell Harris as Chief Strategy Officer and Professor Gil McVean as Chief Information Officer.

Press releases

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Genomics plc bolsters executive leadership team with two new hires


25 Nov 2022

Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.

Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches


10 Oct 2022

Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Genomics plc’s integrated risk tool substantially improves coronary artery disease prediction


3 Mar 2021

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention

Genomics plc completes oversubscribed $30m funding round


1 Mar 2021

Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a $30m funding round. Some highlights include:
· Follows achievement of significant milestones in both its Precision Health and Therapeutics division
· Significant investment from leading life science investors Foresite Capital and F-Prime Capital
· Existing backers Oxford Sciences Innovation and Lansdowne Partners also participated
· Fundraise was oversubscribed
Genomics plc will use the funding to expand its work building a patient-centric, population health platform that unlocks a more proactive, precise and personalised form of healthcare.

Genomics plc grows its senior management team


5 Oct 2020

Daniel Vogel joins Genomics plc as Chief Financial Officer, adding international commercial and financial expertise.

Mitchell Harris joins Genomics plc as Chief Strategy Officer


9 Mar 2020

Genomics plc strengthens leadership team with the addition of Mitchell Harris as Chief Strategy Officer and Professor Gil McVean as Chief Information Officer.

Press releases

Genomics plc selected as one of Bloomberg’s 25 UK Startups to Watch


24 Oct 2023

Genomics plc has been selected from among more than 1,500 applications to be included in Bloomberg’s inaugural 25 UK Startups to Watch list. Bloomberg canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene. The Editors wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK. Genomics plc co-Founder, Professor Sir Peter Donnelly, was also one of three founders from companies in the list to be on stage at the Bloomberg Technology Summit to discuss the Genomics plc story and the wider life sciences/tech sector.

Read article

Genomics plc bolsters executive leadership team with two new hires


25 Nov 2022

Genomics plc has today announced that Mark Toms and Nick DeFilippo have joined its leadership team as Chief Medical Officer and Chief Commercial Officer, respectively. Both join the company’s executive leadership team.

Read article

Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches


10 Oct 2022

Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.

Read article

Genomics plc announces extension of drug discovery collaboration with Vertex


3 Nov 2021

Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery

Read article

Genomics plc announces publication of article showing improved risk prediction for cardiovascular disease across ethnicities


6 Apr 2021

• Polygenic risk scores (PRS) substantially enhance risk prediction in cardiovascular disease (CVD), the #1 cause of death around the world
• These study results represent the first clinical validation of such a tool across multiple ancestries and ethnicities

Read article

Genomics plc’s integrated risk tool substantially improves coronary artery disease prediction


3 Mar 2021

• Genomics plc’s method outperforms current tools and could help save more than 2,000 lives annually in the US alone
• Opportunity to identify individuals who are at risk of heart disease and target immediate prevention

Read article

Genomics plc completes oversubscribed $30m funding round


1 Mar 2021

Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a $30m funding round. Some highlights include:
· Follows achievement of significant milestones in both its Precision Health and Therapeutics division
· Significant investment from leading life science investors Foresite Capital and F-Prime Capital
· Existing backers Oxford Sciences Innovation and Lansdowne Partners also participated
· Fundraise was oversubscribed
Genomics plc will use the funding to expand its work building a patient-centric, population health platform that unlocks a more proactive, precise and personalised form of healthcare.

Read article

Genomics plc grows its senior management team


5 Oct 2020

Daniel Vogel joins Genomics plc as Chief Financial Officer, adding international commercial and financial expertise.

Read article

Mitchell Harris joins Genomics plc as Chief Strategy Officer


9 Mar 2020

Genomics plc strengthens leadership team with the addition of Mitchell Harris as Chief Strategy Officer and Professor Gil McVean as Chief Information Officer.

Read article